Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,676 | 50,347 | 43,915 | 195,579 | 55,516 |
| Marketable Securities | 875,936 | 880,093 | 898,348 | 767,397 | 306,563 |
| TOTAL | $907,216 | $936,649 | $945,724 | $966,335 | $367,225 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,105 | 1,239 | 1,115 | 1,183 | 1,265 |
| TOTAL | $1,105 | $1,239 | $1,115 | $1,183 | $1,265 |
| Total Assets | $908,321 | $937,888 | $946,839 | $967,518 | $368,490 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,813 | 254 | 11,090 | 5,225 | 7,512 |
| TOTAL | $27,413 | $25,685 | $25,093 | $32,774 | $19,135 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 630 | 755 | 766 | 852 | 936 |
| TOTAL | $630 | $755 | $766 | $852 | $936 |
| Total Liabilities | $28,043 | $26,440 | $25,859 | $33,626 | $20,071 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 112,248 | 111,436 | 110,796 | 110,268 | 100,488 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -487,907 | -452,490 | -427,550 | -405,299 | -377,944 |
| Other shareholders' equity | -788 | 1,632 | -2,272 | -1,599 | -184 |
| TOTAL | $880,278 | $911,448 | $920,980 | $933,892 | $348,419 |
| Total Liabilities And Equity | $908,321 | $937,888 | $946,839 | $967,518 | $368,490 |